These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2754366)

  • 21. Central inhibition by gamma-aminobutyric acid and muscimol of the release of vasopressin and oxytocin by an osmotic stimulus in the rat.
    Bisset GW; Chowdrey HS; Fairhall KM; Gunn LK
    Br J Pharmacol; 1990 Mar; 99(3):529-35. PubMed ID: 2331582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone release from isolated nerve endings of the rat neurohypophysis.
    Cazalis M; Dayanithi G; Nordmann JJ
    J Physiol; 1987 Sep; 390():55-70. PubMed ID: 2450999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. gamma-Aminobutyric acid antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants.
    Sladek CD; Armstrong WE
    Endocrinology; 1987 Apr; 120(4):1576-80. PubMed ID: 2435537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caudal ventrolateral medulla can alter vasopressin and arterial pressure.
    Sved AF; Blessing WW; Reis DJ
    Brain Res Bull; 1985 Mar; 14(3):227-32. PubMed ID: 3995365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro.
    Bridges TE; Hillhouse EW; Jones MT
    J Physiol; 1976 Sep; 260(3):647-66. PubMed ID: 988183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of gamma-aminobutyric acid-receptors of the B-subtype inhibits the dopamine-induced enhancement of the release of cholecystokinin-like immunoreactivity from slices of rat dorsal caudatoputamen.
    Conzelmann U; Meyer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):541-6. PubMed ID: 3039381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioid binding in a rat neurohypophysial fraction enriched in oxytocin and vasopressin nerve endings.
    Falke N; Martin R
    Neurosci Lett; 1985 Oct; 61(1-2):37-41. PubMed ID: 2867504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABA and gonadotropin secretion: evidence from in vitro studies on regulation of LHRH secretion.
    Masotto C; Negro-Vilar A
    Adv Biochem Psychopharmacol; 1986; 42():243-50. PubMed ID: 3532698
    [No Abstract]   [Full Text] [Related]  

  • 30. GABAergic control of Arg-vasopressin release from suprachiasmatic nucleus slice culture.
    Isobe Y; Nishino H
    Brain Res; 1997 May; 755(2):213-20. PubMed ID: 9175889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirements for hormone release from permeabilized nerve endings isolated from the rat neurohypophysis.
    Cazalis M; Dayanithi G; Nordmann JJ
    J Physiol; 1987 Sep; 390():71-91. PubMed ID: 2451000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of the role of gamma-aminobutyric acid in the hypothalamic control of feed intake in sheep.
    Girard CL; Seoane JR; Matte JJ
    Can J Physiol Pharmacol; 1985 Oct; 63(10):1297-301. PubMed ID: 4075252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-talk between excitatory and inhibitory amino acids in the regulation of luteinizing hormone-releasing hormone secretion.
    Donoso AO; López FJ; Negro-Vilar A
    Endocrinology; 1992 Sep; 131(3):1559-61. PubMed ID: 1354606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The electrical activity of the hippocampus in rats centrally administered GABA agonists and antagonists].
    Iarkov AV; Vorob'ev VV; Gal'chenko AA; Kovalev GI
    Fiziol Zh SSSR Im I M Sechenova; 1989 Dec; 75(12):1677-85. PubMed ID: 2560722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo studies of GABAergic effects in experimental hepatic encephalopathy.
    Rzepczynski D; Zieve L; Lindblad S; LaFontaine D
    Hepatology; 1986; 6(5):902-5. PubMed ID: 3758944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local regulation of vasopressin and oxytocin secretion by extracellular ATP in the isolated posterior lobe of the rat hypophysis.
    Sperlágh B; Mergl Z; Jurányi Z; Vizi ES; Makara GB
    J Endocrinol; 1999 Mar; 160(3):343-50. PubMed ID: 10076181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on the release mechanism of vasopressin and oxytocin.
    Hashimoto H; Noto T; Nakajima T
    Neuropeptides; 1988; 12(4):199-206. PubMed ID: 3237319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gamma-aminobutyric acid-glutamate interaction in the control of somatostatin release from hypothalamic neurons in primary culture: in vivo corroboration.
    Rage F; Benyassi A; Arancibia S; Tapia-Arancibia L
    Endocrinology; 1992 Feb; 130(2):1056-62. PubMed ID: 1346378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
    Ciosek J
    J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. gamma-Aminobutyric acid antagonist blocks baroreceptor-activated inhibition of neurosecretory cells in the hypothalamic paraventricular nucleus of rats.
    Kasai M; Osaka T; Inenaga K; Kannan H; Yamashita H
    Neurosci Lett; 1987 Oct; 81(3):319-24. PubMed ID: 3431746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.